Timeline
Ftse 100
GSK's Bexsero booster filing accepted by EMA
Health & Bio Today: Eli Lilly to acquire AtaiBeckley depression asset, GSK, Thalia Therapeutics
Aston Martin confirms it is weighing debt financing options
GSK drops camlipixant after mixed phase III cough trial results
Trustpilot bookings jump 18% on 'AI tailwind'
Mining Today: Rio Tinto cuts copper costs on strong H1, Vast Resources, Beowulf Mining, Ferrexpo, Iofina, Savannah Resources
GSK completes Nuvalent acquisition, adding lung cancer drugs
The Premarket Brief: Rio Tinto cuts copper costs as miners hold guidance, Dr Martens, Antofagasta, Hunting, James Cropper, Audioboom, B&M, Zegona, Barratt Redrow
Rio Tinto cuts copper cost guidance as H1 output rises 3%
Dr Martens repeats full year guidance
Health & Bio Today: Poolbeg raises £3.5m for trials, CelLBxHealth, Genus, genedrive, Spire Healthcare, AstraZeneca
AstraZeneca licenses lung cancer drug for up to $1.5bn
Helium One books first sales from US project
Watches of Switzerland posts record £1.8bn revenue, confirms FY27 outlook
Health & Bio Today: Genflow's dog longevity data holds up, Aptamer Group, GSK
DB repeats Sell rating on AstraZeneca on Wainua trial miss
Analyst questions whether Greggs performance rolls through second half
The Morning Brief: Brave Bison, PageGroup, GSK, Plus500, Aptamer Group, Helix, Avation, Rank Group, Henry Boot, Nichols, GKP
GSK's Jemperli hits primary goal in rectal cancer trial
Analyst eyes hydration headwinds at Unilever, so sticks with a Hold rating
Health & Bio Today: Minister cites Genedrive hearing test in Commons, GSK
Hansoh Phase III win bolsters GSK's global case for Ris-Rez in lung cancer
Health & Bio Today: AstraZeneca ATTR-CM trial fails primary endpoint, Avacta, Spire Healthcare, Smith+Nephew
The Morning Brief: Capita profit warning, AstraZeneca trial failure, Severn Trent, Workspace, Playtech, Computacenter, Global Data, Smith+Nephew
AstraZeneca and Ionis ATTR-CM trial fails primary endpoint
Boku cuts full-year guidance after carrier billing suspensions and slower merchant onboarding
Greatland Resources names new COO ahead of Havieron push
The Morning Brief: Boku cuts guidance on carrier billing disruption, Vistry, Unite Group, Jet2, Capita, Hammerson
Rio Tinto exits Kasiya as Sovereign Metals pivots to US critical minerals strategy
Shell flags Middle East conflict impact on Qatar gas volumes in Q2 update
Mining Today: Greatland Gold beats FY26 production guidance, Conroy Gold, Phoenix Copper, Oriole Resources, Panther Metals
The Premarket Brief: Greatland Gold beats FY26 output guidance, ITV sells M&E unit to Sky for £1.6bn, easyJet, Ocado
Greatland Resources beats FY26 gold guidance
Cobra Resources appoints former Rio Tinto executive as strategic advisor
Currys shares dampened by profit takers but analysts stay bullish
The Premarket Brief: Genel Energy acquires Capricorn in recommended cash deal, Braemar, Currys, Ryanair
Lloyds axes Halifax brand after 173 years
National Grid Ventures takes 35% stake in US data centre power firm Joulent
NatWest completes £2.7bn Evelyn Partners acquisition to create UK wealth management leader
Greggs CFO Richard Hutton to Retire After 28 Years
The Premarket Brief: CMC Markets lifts guidance, ABF, Chemring, NatWest . . .
Mining Today: Greatland Gold reserves jump 62% to 5m ounces, Andrada Mining, Savannah Resources, Fulcrum Metals, Ferrexpo
Tech Today: BT and Verizon merge international units in $4bn JV, Cloudified, Arcontech, Trustpilot
Health & Bio Today: Creo Medical lifts FY26 guidance after Q1 beat, Verici Dx, Futura Medical, genedrive, AstraZeneca
Trustpilot Group shares gain as new Shopify partnership is unveiled
British American Tobacco to cut 9,000 jobs in AI-enabled restructuring
Greatland Gold reserves jump 62% to 5m ounces after Telfer drilling program
AstraZeneca's Datroway wins EU approval recommendation for first-line triple-negative breast cancer
Mining Today: Arc Minerals posts full-year loss after Anglo American JV exit, Greenroc Strategic Materials, BHP, Guardian Metal Resources, Talon Resources
More in Markets
Halo Minerals posts interim loss as Playa Verde advances
The AIM-listed copper developer reported a £2.9 million first-half loss, largely non-cash, as it pushed its Chilean tailings project toward a final investment decision.